Oocyte donation: insights gleaned and future challenges
- PMID: 30396566
- DOI: 10.1016/j.fertnstert.2018.09.021
Oocyte donation: insights gleaned and future challenges
Abstract
With the first successful report of an IVF pregnancy achieved via donor oocytes in 1984, the applications of assisted reproductive technology (ART) were further expanded to include women unable to conceive with their own oocytes. Today, oocyte donation makes up an increasingly large percentage of all ART cycles worldwide. Oocyte donation presents several unique challenges to clinicians as two separate interests, those of the donor and those of the recipient, must be represented. These challenges include successful preparation of the endometrium in donor oocyte recipients, the synchronization of donor/recipient cycles, and the optimization of ovarian stimulation while maximizing donor safety. Facing these challenges has not only allowed for the creation of successful donor egg programs but has also provided insights into many aspects of ART. Much of what we know about the window of implantation, frozen ET procedures, triggering of oocyte maturation, and fertility preservation has been learned through experience and investigations with donor egg cycles. Not only has oocyte donation, through its optimization and wide use, provided new treatment opportunities for patients, it has also become a critical scientific tool to study many aspects of menstrual cycle dynamics and implantation. Concomitantly, with its increased efficiency, it has also raised several clinical and ethical challenges.
Keywords: Oocyte donation; donor safety; endometrial preparation; synchronization.
Copyright © 2018. Published by Elsevier Inc.
Similar articles
-
Innovations in assisted reproductive technologies: impact on contemporary donor egg practice and future advances.Fertil Steril. 2018 Nov;110(6):994-1002. doi: 10.1016/j.fertnstert.2018.09.020. Fertil Steril. 2018. PMID: 30396567 Review.
-
Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology.Fertil Steril. 2014 May;101(5):1331-6. doi: 10.1016/j.fertnstert.2014.01.056. Epub 2014 Mar 11. Fertil Steril. 2014. PMID: 24626061
-
Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer.Hum Reprod. 2016 Aug;31(8):1755-64. doi: 10.1093/humrep/dew099. Epub 2016 May 1. Hum Reprod. 2016. PMID: 27141040
-
Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies.Fertil Steril. 2007 Aug;88(2):342-9. doi: 10.1016/j.fertnstert.2006.11.118. Epub 2007 Feb 28. Fertil Steril. 2007. PMID: 17335819
-
Oocyte cryopreservation for donor egg banking.Reprod Biomed Online. 2011 Sep;23(3):341-6. doi: 10.1016/j.rbmo.2011.05.014. Epub 2011 May 27. Reprod Biomed Online. 2011. PMID: 21767989 Review.
Cited by
-
Resistant ovary syndrome: Pathogenesis and management strategies.Front Med (Lausanne). 2022 Oct 19;9:1030004. doi: 10.3389/fmed.2022.1030004. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36341241 Free PMC article. Review.
-
Agonist triggering in oocyte donation programs-Mini review.Front Endocrinol (Lausanne). 2022 Aug 26;13:838236. doi: 10.3389/fendo.2022.838236. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36093096 Free PMC article. Review.
-
Estimates of global research productivity in primary ovarian insufficiency from 2000 to 2021: Bibliometric analysis.Front Endocrinol (Lausanne). 2022 Oct 26;13:959905. doi: 10.3389/fendo.2022.959905. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387882 Free PMC article.
-
A sharing oocyte donation program: a 15-year cohort stud.JBRA Assist Reprod. 2023 Sep 12;27(3):348-354. doi: 10.5935/1518-0557.20220056. JBRA Assist Reprod. 2023. PMID: 37134011 Free PMC article.
-
The pathophysiological role of estrogens in the initial stages of pregnancy: molecular mechanisms and clinical implications for pregnancy outcome from the periconceptional period to end of the first trimester.Hum Reprod Update. 2023 Nov 2;29(6):699-720. doi: 10.1093/humupd/dmad016. Hum Reprod Update. 2023. PMID: 37353909 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical